Sent her a nice mail with the following but did no
Post# of 148183
(Total Views: 446)
Posted On: 03/06/2020 1:42:23 PM
Re: Bored Lawyer #20426
Sent her a nice mail with the following but did not want to make it crazy over the top....and I am fairly new some of it needs a bit of experience and polish on the science, it is close enough for government work, lol
FYI….Leronlimab is an HIV CCR5 blocker and has treated over 800 patients (crazy safe), being presented at CROI as the only late breaker since the Brown CCR5 data/patient, and will announce the filing of an IND for corona in the USA on Monday. The proposed MOA for corona is saving patients from the major cause of death, Acute Respiratory Failure. New York Presbyterian Brooklyn Methodist
may be one of the locations for the phase 2 trial. This Sunday SUNDAY (3/
: Conference on Retroviruses and Opportunistic Infections, Boston (4 days). CytoDyn (OTCQB:CYDY): Preclinical on PRO 140 supporting preexposure prophylaxis.
Have a great weekend end!
Scott
FYI….Leronlimab is an HIV CCR5 blocker and has treated over 800 patients (crazy safe), being presented at CROI as the only late breaker since the Brown CCR5 data/patient, and will announce the filing of an IND for corona in the USA on Monday. The proposed MOA for corona is saving patients from the major cause of death, Acute Respiratory Failure. New York Presbyterian Brooklyn Methodist
may be one of the locations for the phase 2 trial. This Sunday SUNDAY (3/
: Conference on Retroviruses and Opportunistic Infections, Boston (4 days). CytoDyn (OTCQB:CYDY): Preclinical on PRO 140 supporting preexposure prophylaxis. Have a great weekend end!
Scott
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼